(Q48634157)

13 February 2018

title

Mechanism-based PK/PD modeling of the respiratory depressant effect of buprenorphine and fentanyl in healthy volunteers. (English)

1 reference

13 February 2018

0 references

Yassen A

1

1 reference

13 February 2018

Olofsen E

2

1 reference

13 February 2018

Romberg R

3

1 reference

13 February 2018

Sarton E

4

1 reference

13 February 2018

Teppema L

5

1 reference

13 February 2018

Danhof M

6

1 reference

13 February 2018

Dahan A

7

1 reference

13 February 2018

language of work or name

English

0 references

publication date

1 January 2007

1 reference

13 February 2018

Clinical Pharmacology & Therapeutics

published in

1 reference

13 February 2018

volume

81

1 reference

13 February 2018

issue

1

1 reference

13 February 2018

page(s)

50-58

1 reference

13 February 2018

The animal pharmacology of buprenorphine, an oripavine analgesic agent

cites work

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CLPT.6100025

Comparative pharmacodynamics of eight calcium channel blocking agents in Japanese essential hypertensive patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CLPT.6100025

Steady-state propofol brain:plasma and brain:blood partition coefficients and the effect-site equilibration paradox.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CLPT.6100025

The influence of oxygen on the ventilatory response to carbon dioxide in man.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CLPT.6100025

Model appropriateness and population pharmacokinetic modeling

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CLPT.6100025

Simultaneous modeling of pharmacokinetics and pharmacodynamics: application to d-tubocurarine

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CLPT.6100025

Respiratory depression with patient-controlled analgesia

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CLPT.6100025

7 January 2021

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CLPT.6100025

7 January 2021

Differential binding properties of oripavines at cloned mu- and delta-opioid receptors

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CLPT.6100025

7 January 2021

Comparison of the respiratory effects of intravenous buprenorphine and fentanyl in humans and rats

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CLPT.6100025

7 January 2021

Pharmacokinetic-pharmacodynamic modeling of the antinociceptive effect of buprenorphine and fentanyl in rats: role of receptor equilibration kinetics

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CLPT.6100025

7 January 2021

Mechanism-based pharmacokinetic-pharmacodynamic modeling of the antinociceptive effect of buprenorphine in healthy volunteers

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CLPT.6100025

7 January 2021

Mechanism-based pharmacokinetic-pharmacodynamic modeling of the respiratory-depressant effect of buprenorphine and fentanyl in rats.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CLPT.6100025

7 January 2021

Clinical actions of fentanyl and buprenorphine. The significance of receptor binding.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CLPT.6100025

7 January 2021

Buprenorphine: High-Affinity Binding to Dorsal Spinal Cord

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CLPT.6100025

7 January 2021

Naloxone reversal of buprenorphine-induced respiratory depression

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CLPT.6100025

7 January 2021

A preclinical comparison between different opioids: antinociceptive versus adverse effects

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CLPT.6100025

7 January 2021

Clinical pharmacology of buprenorphine: ceiling effects at high doses

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CLPT.6100025

7 January 2021

Opioid receptor imaging and displacement studies with [6-O-[11C] methyl]buprenorphine in baboon brain.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CLPT.6100025

7 January 2021

mu-Opioid receptor-stimulated guanosine-5'-O-(gamma-thio)-triphosphate binding in rat thalamus and cultured cell lines: signal transduction mechanisms underlying agonist efficacy

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CLPT.6100025

7 January 2021

Electroencephalographic quantitation of opioid effect: comparative pharmacodynamics of fentanyl and sufentanil

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CLPT.6100025

7 January 2021

Comparative tissue concentration profiles of fentanyl and alfentanil in humans predicted from tissue/blood partition data obtained in rats

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CLPT.6100025

7 January 2021

Xpose--an S-PLUS based population pharmacokinetic/pharmacodynamic model building aid for NONMEM

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CLPT.6100025

7 January 2021

Building population pharmacokineticpharmacodynamic models. I. Models for covariate effects

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CLPT.6100025

7 January 2021

Anesthetic potency and influence of morphine and sevoflurane on respiration in mu-opioid receptor knockout mice

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CLPT.6100025

7 January 2021

Identifiers

DOI

10.1038/SJ.CLPT.6100025

1 reference

13 February 2018

PubMed ID

17185999

1 reference

13 February 2018